Market Tracker

03/31 6:02pm ET

Novogen Ltd (NASDAQ:NVGN)

4.30
Delayed Data
As of Mar 31
 +0.03 / +0.70%
Today’s Change
1.51
Today|||52-Week Range
5.97
+106.73%
Year-to-Date

Today’s Trading

Previous close4.27
Today’s open4.31
Day’s range4.15 - 4.39
Volume334,584
Average volume (3 months)875,998
Market cap$28.8M
Dividend yield--
Data as of 4:00pm ET, 03/31/2015

Growth & Valuation

Earnings growth (last year)+18.04%
Earnings growth (this year)--
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book23.56

Competitors

 Today’s
change
Today’s
% change
BIODBiodel Inc+0.01+0.85%
ECTEEcho Therapeutics In...-0.26-10.88%
CYCCCyclacel Pharmaceuti...-0.01-0.66%
PPHMPPeregrine Pharmaceut...-0.03-0.13%
Data as of 4:00pm ET, 03/31/2015

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$6.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
Graham Edmund Kelly
Chief Financial Officer &
Non-Executive Director
Steven Coffey
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts